Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
BNB Plus Corp. (BNBX)
USD0.16
+0.00 (+0.00%)
US NASDAQ Healthcare Biotechnology
Address
50 Health Sciences Drive 11790
Stony Brook, NY, US
Stony Brook, NY, US
CEO
Clay D. Shorrock
Website
bnbx.io
IPO
2025-10-08
CIK 744452 ISIN US03815U6073
Also trades on
NASDAQ Capital Market · APDN (USD)
NASDAQ Global Market · BNBX (USD)
Description
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.16
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
957.0K
Beta
0.47
Float Shares
1.05M
Free Float %
81.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.38% | -8.33% | -25.30% | -45.00% | -84.00% | -64.23% | -95.45% | -100.00% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.16
Quality scores
Altman Z-Score
-47.17
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-37.7% Q1'26: +4.1% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-96.7% Q1'26: +99.7% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-697.8% Q1'26: -200.1% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-750.9% Q1'26: -208.7% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-3,435.1% Q1'26: -76.5% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+389.5% Q1'26: +8,136.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.01× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|
| Revenue |
3.43M
est: 3.51M (-2.2%)
|
2.14M
est: 5.28M (-59.6%)
|
7.40M
7.40M – 7.40M
+40.0% YoY
|
| EBITDA |
-13.33M
est: -3.10M (-330.2%)
|
-15.66M
est: -4.67M (-235.7%)
|
-6.53M
-6.53M – -6.53M
-40.0% YoY
|
| EBIT |
-14.02M
est: -3.22M (-335.7%)
|
-16.05M
est: -4.85M (-230.9%)
|
-6.79M
-6.79M – -6.79M
-40.0% YoY
|
| Net Income |
-6.99M
est: -1.69B (+99.6%)
|
-15.16M
est: -186.36M (+91.9%)
|
-42.71M
-42.71M – -42.71M
+77.1% YoY
|
| SGA |
11.45M
est: 8.16M (+40.3%)
|
10.87M
est: 12.29M (-11.6%)
|
17.21M
17.21M – 17.21M
+40.0% YoY
|
| EPS |
-68.25
est: -3,270.00 (+97.9%)
|
-134.23
est: -360.00 (+62.7%)
|
-82.50
-82.50 – -82.50
+77.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-14.07M
OE per share TTM
-7.94
Owner's Yield
-328.42%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
19.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
25
Total invested
227.1K
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
25
+5 vs prev Q
New positions
11
Closed positions
6
Increased
14
Reduced
3
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | GALAXY DIGITAL INC. | 120.5K +120.5K (+100.0%) | 77.1K +77.1K (+100.0%) | 1.35% +1.350 pp | 0.01% +0.007 pp | USD0.64 +0.0% | 1 qtrs NEW |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 76.6K +47.8K (+166.1%) | 49.0K +13.6K (+38.5%) | 0.86% +0.535 pp | 0.00% +0.000 pp | USD0.86 -25.6% | 2 qtrs — |
| 3 | CITADEL ADVISORS LLC | 61.8K +61.8K (+100.0%) | 39.6K +39.6K (+100.0%) | 0.69% +0.693 pp | 0.00% +0.000 pp | USD0.64 +0.0% | 1 qtrs NEW |
| 4 | TWO SIGMA SECURITIES, LLC | 28.7K +28.7K (+100.0%) | 18.4K +18.4K (+100.0%) | 0.32% +0.322 pp | 0.00% +0.002 pp | USD0.64 +0.0% | 1 qtrs NEW |
| 5 | VANGUARD FIDUCIARY TRUST CO | 16.7K +16.7K (+100.0%) | 10.7K +10.7K (+100.0%) | 0.19% +0.187 pp | 0.00% +0.000 pp | USD0.64 +0.0% | 1 qtrs NEW |
| 6 | XTX TOPCO LTD | 13.7K +13.7K (+100.0%) | 8.8K +8.8K (+100.0%) | 0.15% +0.153 pp | 0.00% +0.000 pp | USD0.64 +0.0% | 1 qtrs NEW |
| 7 | SABBY MANAGEMENT, LLC | 13.5K -40.5K (-74.9%) | 8.7K -57.8K (-87.0%) | 0.15% -0.453 pp | 0.02% -0.076 pp | USD1.23 -48.0% | 4 qtrs — |
| 8 | VIRTU FINANCIAL LLC | 10.5K +10.5K (+100.0%) | 7.0K +7.0K (+100.0%) | 0.12% +0.118 pp | 0.00% +0.000 pp | USD0.64 +0.0% | 1 qtrs NEW |
| 9 | UBS GROUP AG | 8.6K +4.5K (+108.5%) | 5.5K +432.0 (+8.5%) | 0.10% +0.050 pp | 0.00% +0.000 pp | USD2.19 -70.8% | 4 qtrs — |
| 10 | TOWER RESEARCH CAPITAL LLC (TRC) | 3.2K -360.0 (-10.0%) | 2.1K -2.4K (-53.2%) | 0.04% -0.004 pp | 0.00% 0.000 pp | USD1.86 -65.6% | 4 qtrs — |
| 11 | — | 386.00 +386.0 (+100.0%) | 247.00 +247.0 (+100.0%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD0.64 +0.0% | 1 qtrs NEW |
| 12 | SBI SECURITIES CO., LTD. | 145.00 -1.0 (-0.7%) | 93.00 -87.0 (-48.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.22 -47.5% | 4 qtrs — |
| 13 | BLACKROCK, INC. | 4.00 +— (+0.0%) | 3.00 -2.0 (-40.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.75 -82.9% | 4 qtrs — |
| 14 | MAI CAPITAL MANAGEMENT | 2.00 +— (+0.0%) | 2.00 -1.0 (-33.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.50 -81.7% | 4 qtrs — |
| 15 | WELLS FARGO & COMPANY/MN | 2.00 +— (+0.0%) | 2.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.50 -81.7% | 4 qtrs — |
| 16 | MORGAN STANLEY | 3.00 +— (+0.0%) | 2.00 -2.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.67 -82.6% | 4 qtrs — |
| 17 | ADVISOR GROUP HOLDINGS, INC. | 4.00 +1.0 (+33.3%) | 1.00 -2.0 (-66.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.75 -76.7% | 4 qtrs — |
| 18 | ADVISORY SERVICES NETWORK, LLC | 1.00 +1.0 (+100.0%) | 1.00 +1.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs — |
| 19 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 1.00 +1.0 (+100.0%) | 1.00 +1.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 1 qtrs NEW |
| 20 | COMMUNITY FINANCIAL SERVICES GROUP, LLC | 1.00 +1.0 (+100.0%) | 1.00 +1.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 1 qtrs NEW |
| 21 | DANSKE BANK A/S | 1.00 +— (+0.0%) | 1.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -78.7% | 4 qtrs — |
| 22 | KOHMANN BOSSHARD FINANCIAL SERVICES, LLC | 1.00 +— (+0.0%) | 1.00 -1.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 -36.0% | 2 qtrs — |
| 23 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 1.00 +1.0 (+100.0%) | 1.00 +1.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 1 qtrs NEW |
| 24 | WEALTH PRESERVATION ADVISORS, LLC | 1.00 +— (+0.0%) | 1.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -78.7% | 4 qtrs — |
| 25 | WESTSIDE INVESTMENT MANAGEMENT, INC. | 1.00 +— (+0.0%) | 1.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -78.7% | 4 qtrs — |
| 26 | NATIXIS | — -1.0 (-100.0%) | — -1.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 27 | CITIGROUP INC | — -1.0 (-100.0%) | — -1.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Nuveen Securitized Income NSCI | 0.55% | 973.1K | 0.38% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 159.29 | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
11
Sells
0
Shares acquired
314.9K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+314,893
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-27 | SHAMASH YACOV A | Director | A-Award | A | Incentive Stock Option (right to buy) | 77,038 | 0.69 | 53.2K | 77,038 | D | ↗ |
| 2026-03-27 | Murrah Judith | Director | A-Award | A | Incentive Stock Option (right to buy) | 77,038 | 0.69 | 53.2K | 77,038 | D | ↗ |
| 2026-03-27 | Kruger Joshua | Director | A-Award | A | Incentive Stock Option (right to buy) | 77,038 | 0.69 | 53.2K | 77,038 | D | ↗ |
| 2026-03-27 | Haft James | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 77,038 | 0.69 | 53.2K | 77,038 | D | ↗ |
| 2026-03-27 | Ceccoli Joseph D. | Director | A-Award | A | Incentive Stock Option (right to buy) | 77,038 | 0.69 | 53.2K | 77,038 | D | ↗ |
| 2026-03-27 | CATELL ROBERT B | Director | A-Award | A | Incentive Stock Option (right to buy) | 77,038 | 0.69 | 53.2K | 77,038 | D | ↗ |
| 2026-02-02 | Haft James | Director | A-Award | A | Incentive Stock Option (right to buy) | 80,730 | 1.31 | 105.8K | 80,730 | D | ↗ |
| 2025-12-15 | Shorrock Clay | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 42,194 | 2.52 | 106.3K | 42,194 | D | ↗ |
| 2025-12-15 | Jantzen Beth | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 42,194 | 2.52 | 106.3K | 42,194 | D | ↗ |
| 2025-11-06 | Kruger Joshua | Director | — | — | Common Stock | 0 | 0.00 | — | 75,302 | D | ↗ |
| 2025-10-17 | Shorrock Clay | Officer | A-Award | A | Common Stock | 18,691 | 0.00 | — | 18,695 | D | ↗ |
| 2025-10-17 | Schmalz Elizabeth M | Director | A-Award | A | Common Stock | 22,511 | 0.00 | — | 22,512 | D | ↗ |
| 2025-10-17 | SHAMASH YACOV A | Director | A-Award | A | Common Stock | 22,511 | 0.00 | — | 22,512 | D | ↗ |
| 2025-10-17 | Murrah Judith | Director | A-Award | A | Common Stock | 18,691 | 0.00 | — | 18,694 | D | ↗ |
| 2025-10-17 | Jantzen Beth | Officer | A-Award | A | Common Stock | 18,691 | 0.00 | — | 18,694 | D | ↗ |
| 2025-10-17 | Ceccoli Joseph D. | Director | A-Award | A | Common Stock | 22,511 | 0.00 | — | 22,512 | D | ↗ |
| 2025-10-17 | CATELL ROBERT B | Director | A-Award | A | Common Stock | 22,511 | 0.00 | — | 22,512 | D | ↗ |
| 2025-10-03 | Kruger Joshua | Director | — | — | Series E-1 Warrants | 75,302 | 3.82 | 287.7K | 0 | D | ↗ |
Executive team
Top executives
EBIT / Employee
-3.5K
Shares Outstanding
1.29M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Judith Murrah | Director, Strategic Transition Advisor & Secretary | 754.7K | female |
| Clay Shorrock | President & Chief Executive Officer | 368.7K | male |
| Beth Jantzen | Chief Financial Officer | 365.4K | female |
| Patrick Brian Horsman | Chief Investment Officer | — | male |
| Sanjay Hurry | Executive Director of Investor Relations & Corporate Communications | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BNBX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
